Finance

Lists
Why is 524516 down 4.74%?
Dive Deeper
524516:BOM
Bacil Pharma Ltd
₹21.93
-4.74%
(-1.09) 1D
Oct 15, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524516...
Open
₹22.56
High
₹22.56
Low
₹21.92
Mkt. cap
314.76M
Avg. vol.
49.98K
Volume
5.71K
P/E ratio
39.35
52-wk high
₹61.80
52-wk low
₹10.65
EPS
₹0.56
No. of employees
2
Open
₹22.56
High
₹22.56
Low
₹21.92
Mkt. cap
314.76M
Avg. vol.
49.98K
Volume
5.71K
P/E ratio
39.35
52-wk high
₹61.80
52-wk low
₹10.65
EPS
₹0.56
No. of employees
2
News stories
From web sources and news partners
About Bacil Pharma Ltd
CEO-
Employees2
Founded1987
Headquarters-
SectorPharmaceutical industry
Websitebacilpharma.co.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
63.00K
60.00K
109.00K
72.00K
Operating expense
365.00K
253.00K
743.00K
227.00K
Total operating expenses
365.00K
253.00K
743.00K
227.00K
Operating income
-365.00K
-253.00K
-743.00K
-227.00K
Other non operating income
549.00K
645.00K
-1.22M
891.00K
EBT including unusual items
184.00K
392.00K
390.00K
664.00K
EBT excluding unusual items
184.00K
392.00K
390.00K
664.00K
Income tax expense
46.00K
-
-7.95M
825.00K
Effective tax rate
25.00%
-
-2,037.95%
124.25%
Other operating expenses
302.00K
193.00K
634.00K
155.00K
Net income
138.00K
392.00K
8.34M
-161.00K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
2.35M
-
Interest expense
-
-
-
-
Net interest expenses
-
-
2.35M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-363.25K
-251.25K
-741.25K
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps